Century Therapeutics IPSC
NASDAQ IPSC
$1.53 -0.08 (-4.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Cash & Current Investments (2020 - 2026)

Updated

Century Therapeutics (IPSC) recorded Cash & Current Investments of $119.71 million in Q2 2026, down 23.2% from $155.84 million a year earlier and down 11.2% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Century Therapeutics reported Cash & Current Investments of $117.11 million, down 38.1% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $189.29 million in FY2024 (+9.6%), $172.74 million in FY2023 (-45.2%), $315.5 million in FY2022 (+41.6%) and $222.88 million in FY2021 (+194.2%).
  • Quarterly Cash & Current Investments has ranged from $117.11 million in Q4 2025 to $378.76 million in Q2 2022 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has declined for six consecutive quarters, with an average decline of 15.1% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 194.2% in Q4 2021, against a decline of 58.7% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $134.8 million (Q1 2026), $117.11 million (Q4 2025) and $132.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Century Therapeutics 276.24 Mn -228.14 Mn - 119.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.71 Mn
Mar 31, 2026 134.80 Mn
Dec 31, 2025 117.11 Mn
Sep 30, 2025 132.75 Mn
Jun 30, 2025 155.84 Mn
Mar 31, 2025 165.12 Mn
Dec 31, 2024 189.29 Mn
Sep 30, 2024 198.11 Mn
Jun 30, 2024 196.40 Mn
Mar 31, 2024 192.02 Mn
Dec 31, 2023 172.74 Mn
Sep 30, 2023 169.51 Mn
Jun 30, 2023 156.40 Mn
Mar 31, 2023 251.47 Mn
Dec 31, 2022 315.50 Mn
Sep 30, 2022 355.86 Mn
Jun 30, 2022 378.76 Mn
Mar 31, 2022 361.02 Mn
Dec 31, 2021 222.88 Mn
Sep 30, 2021 295.15 Mn
API Access

Century Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IPSC&period=max&api_key=YOUR_API_KEY